Medicine | Oncology
Prostate cancer
Prognosis
Prediction tool: PSA at diagnosis


Home > Disciplines > Medicine > Oncology > Prostate cancer > Prognosis > PSA at diagnosis


Pretreatment PSA




PSA LEVELS OF 20 - 100 ng / mL


.

Iwamoto H, Izumi K, Kadono Y, Mizokami A.
Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 - 100 ng / mL.
Int Braz J Urol. 2019 Jan-Feb;45(1):61-67. doi: 10.1590/S1677-5538.IBJU.2018.0143. Epub 2918 Oct 30.
Source | Full text | Similar articles



.

Joob B, Wiwanitkit V.
Re: Prognosis of prostate cancer and prostate - specific antigen levels.
Int Braz J Urol. 2019 Mar 20;45. doi: 10.1590/S1677-5538.IBJU.2018.0867. [Epub ahead of print]
Source | Full text | Similar articles
Refers to: Iwamoto H, et al., Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 - 100 ng / mL.
Int Braz J Urol. 2019 Jan-Feb;45(1):61-67. doi: 10.1590/S1677-5538.IBJU.2018.0143. Epub 2918 Oct 30.
Source | Full text



BIOCHEMICAL AND CLINICAL FAILURES


.

Kupelian PA, Katcher J, Levin HS, Klein EA.
Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52. DOI: http://dx.doi.org/10.1016/S0360-3016(96)00590-1
Source | Full text | Similar articles



.

Santok GD, Abdel Raheem A, Kim LH, Chang K, Lum TG, Chung BH, Choi YD, Rha KH.
Prostate-specific antigen 10-20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6.
Investig Clin Urol. 2017 Mar;58(2):90-97. doi: 10.4111/icu.2017.58.2.90. Epub 2017 Feb 15.
Source | Full text | Similar articles



PREOPERATIVE PSA VELOCITY


.

Patel DA, Presti JC Jr, McNeal JE, Gill H, Brooks JD, King CR.
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
J Clin Oncol. 2005 Sep 1;23(25):6157-62. DOI: 10.1200/JCO.2005.01.2336
Source | Full text | Similar articles



STATIN USE



Hamilton RJ, Goldberg KC, Platz EA, Freedland SJ.
The influence of statin medications on prostate-specific antigen levels.
J Natl Cancer Inst. 2008 Nov 5;100(21):1511-8. doi: 10.1093/jnci/djn362
Source | Full text | Similar articles



PREDICTION OF METASTASES


.

Singh OP, Yogi V, Redhu P, Ghori HU, Pareek A, Lal N.
Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer.
J Cancer Res Ther. 2019 Mar;15(Supplement):S39-S41. doi: 10.4103/jcrt.JCRT_189_18.
Source | Full text | Similar articles